TOKYO, May 14 (Pulse News Wire) – ADEKA Corporation (4401.T) reported its consolidated financial results for the fiscal year ended March 2026. Revenue increased by 2.3% to 4,165 billion yen compared to the previous fiscal year.
However, revenue for chemicals decreased by 1.7%, while resin additives saw a decline of 6.7%. Notably, life sciences experienced a significant growth of 11.8%. In terms of operating profit, the company recorded a slight increase of 1.5% to 416 billion yen. Life sciences contributed positively with a 26.4% rise in operating profit, offsetting declines in chemicals (-6.0%) and resin additives (-11.6%). Over the past three quarters, ADEKA's performance showed mixed trends across segments.
Sales for chemicals and food remained stable, whereas resin additives faced challenges. Operating profits fluctuated but generally improved quarter-over-quarter. Internationally, ADEKA’s overseas sales accounted for 54.4% of total revenue, down slightly from 54.9% in the prior year. Despite this, Asia saw a notable increase in sales, rising by 83 billion yen to 1,153 billion yen. Sales in the Americas, Europe, Middle East, and others declined by 52 billion yen to 1,111 billion yen overall.
Overall, ADEKA maintained steady progress in key areas despite sector-specific challenges, highlighting resilience in its diverse portfolio.
🟡 Confidence: Standard AI-translated content.